Wednesday, 11 Jun 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • House
  • VIDEO
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Colossal
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Woman Dies After Using Weight-Loss Drug In U.K.’s First Case
Health and Wellness

Woman Dies After Using Weight-Loss Drug In U.K.’s First Case

Last updated: November 9, 2024 9:12 pm
Share
Woman Dies After Using Weight-Loss Drug In U.K.’s First Case
SHARE

A tragic incident has occurred in the U.K. involving a 58-year-old nurse named Susan McGowan who passed away after taking two doses of the weight-loss medication tirzepatide, also known as Mounjaro or Zepbound. According to reports, McGowan’s death was attributed to multiple organ failure, septic shock, and pancreatitis, with the Eli Lilly drug listed as a contributing factor on her death certificate.

McGowan had purchased the prescription for tirzepatide online and had taken two low doses of the drug over a period of two weeks. Shortly after her second dose, she began experiencing severe stomach pain and sickness, prompting her to seek treatment at University Hospital Monklands where she had worked for three decades. Unfortunately, her condition worsened, leading to kidney issues, coma, and eventually organ failure.

Tirzepatide is categorized as a GLP-1 receptor agonist, a class of weight-loss drugs that help reduce appetite by inducing a feeling of fullness. Similar to Novo Nordisk’s Ozempic, tirzepatide is known for its effectiveness in weight loss and managing type two diabetes. However, it is also associated with side effects such as vomiting, diarrhea, and nausea, and in rare cases, severe allergic reactions, kidney problems, stomach issues, and thyroid tumors.

Despite these risks, regulatory authorities maintain that the benefits of tirzepatide outweigh the potential drawbacks. The U.K.’s Medicines and Healthcare products Regulatory Authority approved the drug as a weight loss aid in 2023, closely monitoring adverse events through the Yellow Card reporting scheme. While a second death is under investigation for possible links to tirzepatide, no conclusive evidence has been established.

In response to the incident, Dr. Alison Cave, Chief Safety Officer at MHRA, emphasized the organization’s commitment to patient safety and the rigorous assessment of medicines before approval. Eli Lilly, the manufacturer of tirzepatide, also reiterated its dedication to monitoring and reporting safety information for all its products.

See also  Christian radio host Rob Dempsey dies one week after shocking cancer announcement

As investigations continue into the circumstances surrounding Susan McGowan’s tragic death, it serves as a poignant reminder of the importance of patient safety and thorough evaluation of medication risks and benefits. Our thoughts are with McGowan’s family during this difficult time, and we hope that lessons learned from this incident will contribute to enhanced safety measures in the healthcare industry.

TAGGED:caseDiesDrugU.K.sWeightLossWoman
Share This Article
Twitter Email Copy Link Print
Previous Article Emilia Wickstead Resort 2025 Collection Emilia Wickstead Resort 2025 Collection
Next Article Days Before The Election Trump Melts Down Because He Isn’t Running Against Biden Days Before The Election Trump Melts Down Because He Isn’t Running Against Biden
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Oil and gas money shapes research, creates ‘echo chamber’ in higher education

The issue of fossil fuel funding in universities has come under scrutiny in recent years,…

March 29, 2025

Timeless Wardrobe Tips: 2025 Fashion Resolutions

As we step into a brand-new year, it’s the perfect moment to rethink not just…

December 29, 2024

Social Media Dancer Miranda Derrick Reveals Alleged DM From Drake

Miranda Derrick made headlines recently when she revealed that she had allegedly received a direct…

May 4, 2025

Caleb Kennedy Writing Songs, Will Hopefully Have Career After Prison, Attorney Says

Caleb Kennedy, the 20-year-old singer, is currently working on new music as he prepares for…

November 22, 2024

U.K. Writers Decry ITV’s Plan to Use AI to Generate Show Ideas:

ITV Faces Backlash Over Job Posting for AI Innovation Role ITV, a prominent public service…

October 21, 2024

You Might Also Like

RFK Jr. needs Congress to help create new MAHA agency
Health and Wellness

RFK Jr. needs Congress to help create new MAHA agency

June 11, 2025
Toddler dies after being left in 105-degree car by drunk father for 9 hours
Crime

Toddler dies after being left in 105-degree car by drunk father for 9 hours

June 10, 2025
Accenture plc (ACN): A Bull Case Theory
Economy

Accenture plc (ACN): A Bull Case Theory

June 10, 2025
Microsoft Pulling Major Conference Out of Seattle Due to Rampant Homelessness and Open-Air Drug Use |
Politics

Microsoft Pulling Major Conference Out of Seattle Due to Rampant Homelessness and Open-Air Drug Use |

June 10, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?